Immunodetection assays for the quantification of seasonal common cold coronaviruses OC43, NL63, or 229E infection confirm nirmatrelvir as broad coronavirus inhibitor.

Weil, Tatjana; Lawrenz, Jan; Seidel, Alina; Münch, Jan; Müller, Janis A

Weil, Tatjana; Lawrenz, Jan; Seidel, Alina; Münch, Jan; Müller, Janis A.

Afiliação

Weil T; Institute of Molecular Virology, Ulm University Medical Center, 89081, Ulm, Germany.
Lawrenz J; Institute of Molecular Virology, Ulm University Medical Center, 89081, Ulm, Germany.
Seidel A; Institute of Molecular Virology, Ulm University Medical Center, 89081, Ulm, Germany.
Münch J; Institute of Molecular Virology, Ulm University Medical Center, 89081, Ulm, Germany; Core Facility Functional Peptidomics, Ulm University Medical Center, 89081, Ulm, Germany.
Müller JA; Institute of Molecular Virology, Ulm University Medical Center, 89081, Ulm, Germany; Institute of Virology, Philipps University of Marburg, 35043, Marburg, Germany. Electronic address: Janismueller@uni-marburg.de.

Antiviral Res ; 203: 105343, 2022 07.

Article em En | MEDLINE | ID: mdl-35598779

Assuntos

Tratamento Farmacológico da COVID-19; COVID-19; Resfriado Comum; Coronavirus Humano NL63; Antivirais/farmacologia; COVID-19/diagnóstico; Resfriado Comum/diagnóstico; Resfriado Comum/tratamento farmacológico; Humanos; SARS-CoV-2; Estações do Ano

Palavras-chave

Antiviral testing; Drug screening; In-cell ELISA; Seasonal coronaviruses

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Resfriado Comum / Coronavirus Humano NL63 / COVID-19 / Tratamento Farmacológico da COVID-19 Tipo de estudo: Diagnostic_studies / Guideline / Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google